These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15914275)

  • 21. Gene expression profiling of tumor-stromal interactions between pancreatic cancer cells and stromal fibroblasts.
    Sato N; Maehara N; Goggins M
    Cancer Res; 2004 Oct; 64(19):6950-6. PubMed ID: 15466186
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro and in vivo inhibitory effect evaluation of cyclooxygenase-2 inhibitors, antisense cyclooxygenase-2 cDNA, and their combination on the growth of human bladder cancer cells.
    Qin J; Yuan J; Li L; Liu H; Qin R; Qin W; Chen B; Wang H; Wu K
    Biomed Pharmacother; 2009 Mar; 63(3):241-8. PubMed ID: 18617357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COX-2 regulates p53 activity and inhibits DNA damage-induced apoptosis.
    Choi EM; Heo JI; Oh JY; Kim YM; Ha KS; Kim JI; Han JA
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1107-12. PubMed ID: 15707991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nicotine induces cyclooxygenase-2 and vascular endothelial growth factor receptor-2 in association with tumor-associated invasion and angiogenesis in gastric cancer.
    Shin VY; Wu WK; Chu KM; Wong HP; Lam EK; Tai EK; Koo MW; Cho CH
    Mol Cancer Res; 2005 Nov; 3(11):607-15. PubMed ID: 16317086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer.
    Chu J; Lloyd FL; Trifan OC; Knapp B; Rizzo MT
    Mol Cancer Ther; 2003 Jan; 2(1):1-7. PubMed ID: 12533667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of COX-2 selective inhibitors for prevention and treatment of cancer.
    Amir M; Agarwal HK
    Pharmazie; 2005 Aug; 60(8):563-70. PubMed ID: 16124396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
    J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stimulatory effects of eicosanoids on ovarian angiogenesis in early luteal phase in cyclooxygenase-2 inhibitor-treated rats.
    Sakurai T; Tamura K; Kogo H
    Eur J Pharmacol; 2005 Jun; 516(2):158-64. PubMed ID: 15921676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antisense inhibition of cyclooxygenase-2 reduces malignant phenotype of gastric cancer cells].
    Wu H; Wu K; Yao L; Xu M; Fan D
    Zhonghua Nei Ke Za Zhi; 2002 Aug; 41(8):534-7. PubMed ID: 12421501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dual inhibition of 5-LOX and COX-2 suppresses colon cancer formation promoted by cigarette smoke.
    Ye YN; Wu WK; Shin VY; Bruce IC; Wong BC; Cho CH
    Carcinogenesis; 2005 Apr; 26(4):827-34. PubMed ID: 15637091
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COX-2 inhibitor, NS398, enhances Fas-mediated apoptosis via modulation of the PTEN-Akt pathway in human gastric carcinoma cell lines.
    Honjo S; Osaki M; Ardyanto TD; Hiramatsu T; Maeta N; Ito H
    DNA Cell Biol; 2005 Mar; 24(3):141-7. PubMed ID: 15767780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Delayed rectifier K(+) channel regulated by cyclooxygenase-2 in human gastric cancer cell].
    Wu H; Wu K; Han Y; Shi Y; Yao L; Wang J; Fan D
    Zhonghua Zhong Liu Za Zhi; 2002 Sep; 24(5):440-3. PubMed ID: 12485493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective COX-2 inhibitor, NS-398, inhibits the replicative senescence of cultured dermal fibroblasts.
    Han JH; Roh MS; Park CH; Park KC; Cho KH; Kim KH; Eun HC; Chung JH
    Mech Ageing Dev; 2004 May; 125(5):359-66. PubMed ID: 15130753
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Induction of apoptosis and cell cycle arrest by NS398 in oral squamous cell carcinoma cells via downregulation of E2 promoter-binding factor-1.
    Du Y; Zhang S; Wang Z; Zhou W; Luan M; Yang X; Chen N
    Oncol Rep; 2008 Sep; 20(3):605-11. PubMed ID: 18695912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significance of COX-2 expression in human renal cell carcinoma cell lines.
    Chen Q; Shinohara N; Abe T; Watanabe T; Nonomura K; Koyanagi T
    Int J Cancer; 2004 Mar; 108(6):825-32. PubMed ID: 14712483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nuclear factor-kappaB regulates cyclooxygenase-2 expression and cell proliferation in human gastric cancer cells.
    Lim JW; Kim H; Kim KH
    Lab Invest; 2001 Mar; 81(3):349-60. PubMed ID: 11310828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential effects of COX inhibitors against beta-amyloid-induced neurotoxicity in human neuroblastoma cells.
    Ferrera P; Arias C
    Neurochem Int; 2005 Dec; 47(8):589-96. PubMed ID: 16169124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of cyclooxygenase-2 (COX-2) inhibition on human prostate cancer induced osteoblastic and osteolytic lesions in bone.
    Gamradt SC; Feeley BT; Liu NQ; Roostaeian J; Lin YQ; Zhu LX; Sharma S; Dubinett SM; Lieberman JR
    Anticancer Res; 2005; 25(1A):107-15. PubMed ID: 15816526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
    Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
    Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.